Affordable Access

Publisher Website

In vitro antimicrobial activity of rifaximin against enteropathogens causing traveler's diarrhea

Authors
Journal
Diagnostic Microbiology and Infectious Disease
0732-8893
Publisher
Elsevier
Publication Date
Volume
59
Issue
4
Identifiers
DOI: 10.1016/j.diagmicrobio.2007.07.003
Keywords
  • Rifaximin
  • Traveler'S Diarrhea
  • Eaec
  • Etec
  • Shigella Sonnei

Abstract

Abstract The in vitro activity of rifaximin against 84 diarrheagenic Escherichia coli and 11 Shigella sonnei causing traveler's diarrhea was evaluated. The MIC of rifaximin ranged between <0.007 and 32 mg/L; other agents tested had an MIC of >256 mg/L in most cases. The results showed the potential use of rifaximin to treat these infections.

There are no comments yet on this publication. Be the first to share your thoughts.